معرفی
Robin Duncan is an Associate Professor at the University of Waterloo, leading the Lipid Enzyme Discovery Lab. His research focuses on lipid metabolism, mitochondrial biology, and their roles in cardiovascular health, cancer metabolism, and viral interactions. Specializing in physiology and nutrition, he investigates molecular mechanisms underlying lipid-related disorders using mouse models and biochemical approaches.
Key research areas include: lipid droplet dynamics, mitochondrial cardiolipin regulation, SARS-CoV-2 molecular interactions, and the role of lysophosphatidic acid in metabolic pathways. Recent work highlights discoveries in ApoL6-mediated lipolysis inhibition, Plaat1 deficiency effects on cardiac function, and cannabidiol's mitochondrial impacts.
Publications span over 40 peer-reviewed articles, with 2024-2025 contributions emphasizing lithium isotope effects on mitochondrial transport and renal lipid-glucagon interactions. His lab employs advanced lipidomic techniques like UHPLC-MS/MS and transgenic mouse models to study metabolic pathways.
No formal awards are listed, though his work is funded through grants supporting lipid-metabolism research. He advises graduate students in physiology and biochemistry programs, with active collaborations in cancer metabolism and virology. Current projects include developing novel therapies targeting lipid-related pathologies and investigating cannabinoid-mitochondrial interactions.
